<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1038/s41467-019-09482-6</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">41467</journal-id><journal-title-group><journal-title>Nature Communications</journal-title><abbrev-journal-title abbrev-type="publisher">Nat Commun</abbrev-journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s41467-019-09482-6</article-id><article-id pub-id-type="manuscript">9482</article-id><article-id pub-id-type="doi">10.1038/s41467-019-09482-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/250/127/1213</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/250/256</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/250/256/2177</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/337/384/2568</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/13</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/13/1</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/13/31</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/13/89</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/13/109</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/14/32</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/14/63</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/91</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/90</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/96/21</subject></subj-group><subj-group subj-group-type="NatureArticleTypeID"><subject>article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The lncRNA <italic>Neat1</italic> promotes activation of inflammasomes in macrophages</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Zhang</surname><given-names>Pengfei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Cao</surname><given-names>Limian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au3"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3351-6420</contrib-id><name><surname>Zhou</surname><given-names>Rongbin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au4"><name><surname>Yang</surname><given-names>Xiaolu</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs41467019094826_cor4">d</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au5"><name><surname>Wu</surname><given-names>Mian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs41467019094826_cor5">e</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121679639</institution-id><institution-id institution-id-type="GRID">grid.59053.3a</institution-id><institution content-type="org-division">The Chinese Academy of Sciences (CAS) Key Laboratory of Innate Immunity and Chronic Disease, CAS Center for Excellence in Cell and Molecular Biology, School of Life Sciences</institution><institution content-type="org-name">University of Science and Technology of China</institution></institution-wrap><addr-line content-type="postcode">230026</addr-line><addr-line content-type="city">Hefei</addr-line><country country="CN">China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution content-type="org-division">Department of Cancer Biology and Abramson Family Cancer Research Institute, Perelman School of Medicine</institution><institution content-type="org-name">University of Pennsylvania</institution></institution-wrap><addr-line content-type="postcode">19104</addr-line><addr-line content-type="city">Philadelphia</addr-line><addr-line content-type="state">PA</addr-line><country country="US">USA</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9139 560X</institution-id><institution-id institution-id-type="GRID">grid.256922.8</institution-id><institution content-type="org-division">Translational Research Institute, Henan Provincial People’s Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan Key Laboratory of Stem Cell Differentiation and Modification</institution><institution content-type="org-name">School of Clinical Medicine, Henan University</institution></institution-wrap><addr-line content-type="postcode">450003</addr-line><addr-line content-type="city">Zhengzhou</addr-line><country country="CN">China</country></aff></contrib-group><author-notes><corresp id="IDs41467019094826_cor4"><label>d</label><email>xyang@mail.med.upenn.edu</email></corresp><corresp id="IDs41467019094826_cor5"><label>e</label><email>wumian@ustc.edu.cn</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>2</day><month>4</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>10</volume><issue seq="20196660">1</issue><elocation-id>1495</elocation-id><history><date date-type="registration"><day>15</day><month>3</month><year>2019</year></date><date date-type="received"><day>20</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>3</month><year>2019</year></date><date date-type="online"><day>2</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><p id="Par1">The inflammasome has an essential function in innate immune, responding to a wide variety of stimuli. Here we show that the lncRNA <italic>Neat1</italic> promotes the activation of several inflammasomes. <italic>Neat1</italic> associates with the NLRP3, NLRC4, and AIM2 inflammasomes in mouse macrophages to enhance their assembly and subsequent pro-caspase-1 processing. <italic>Neat1</italic> also stabilizes the mature caspase-1 to promote interleukin-1β production and pyroptosis. Upon stimulation with inflammasome-activating signals, <italic>Neat1</italic>, which normally resides in the paraspeckles, disassociates from these nuclear bodies and translocates to the cytoplasm to modulate inflammasome activation using above mechanism. <italic>Neat1</italic> is also up-regulated under hypoxic conditions in a HIF-2α-dependent manner, mediating the effect of hypoxia on inflammasomes. Moreover, in the mouse models of peritonitis and pneumonia, <italic>Neat1</italic> deficiency significantly reduces inflammatory responses. These results reveal a previously unrecognized role of lncRNAs in innate immunity, and suggest that <italic>Neat1</italic> is a common mediator for inflammasome stimuli.</p></abstract><abstract id="Abs2" xml:lang="en"><p id="Par2">The inflammasomes are important mediators of protective immunity by promoting inflammatory cytokine production and cell death. Here the authors show that a lncRNA, Neat1, is mobilized by inflammasome-activating signals to promote the assembly of several inflammasome complexes and cytokine maturation to regulate inflammation.</p></abstract><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Nature Research</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>15</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>NonStandardArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/41467_2019_Article_9482.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Science (multidisciplinary)</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="AuthorContribution"><p>These authors contributed equally: Pengfei Zhang, Limian Cao.</p></notes></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Inflammasomes are a group of multicomponent signaling platforms in the cytoplasm that control inflammatory response and anti-pathogen defense against a wide range of infection and damage signals<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref></sup>. These signals, including pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs)<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>, directly or indirectly activate one or more innate pattern recognition receptors (PRRs), which include nucleotide-binding domain (NBD) and leucine-rich repeat (LRR)-containing receptors (NLRs, e.g., NLRP1, NLRP3, and NLRC4), cytosolic DNA sensors (AIM2), and Pyrin (also known as TRIM20)<sup><xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref></sup>. Upon activation, the sensor proteins bind to and induce the oligomerization of a common adaptor protein, apoptosis-associated speck-like protein containing CARD (ASC), leading to the formation of a single macromolecular aggregate known as ASC speck<sup><xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup>. Oligomerized ASC recruits pro-caspase-1<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, facilitating its auto-processing into the mature subunits<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Active caspase-1 mediates proteolytic maturation of pro-inflammatory cytokines interleukin 1β (IL-1β) and IL-18 and elicits pyroptosis, a form of programmed cell death that exhibits features of both apoptosis (e.g., DNA fragmentation) and necrosis (e.g., plasma membrane rupture)<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>.</p><p id="Par4">While adequate inflammasome activation is crucial for the elimination of pathogens and damaged cells<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, dysregulation of inflammasome contributes to autoimmune, cancer, neurodegenerative disorders, and other diseases<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Nevertheless, the regulation of inflammasomes is not well understood. Several inflammasomes respond to a limited set of signals. For example, the AIM2 and NLRC4 inflammasomes are assembled upon the sensing of double-stranded DNA (dsDNA) and specific bacterial proteins, respectively<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>, while the inflammasome formed with NLRP1 or its murine homolog Nlrp1b is activated by anthrax lethal toxin (LeTx) and 2-deoxy-D-Glucose (2DG)<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. In contrast, the NLRP3 inflammasome is activated by an extraordinarily diverse array of PAMPs including several viral, bacterial, fungal pathogens, and DAMPs, such as crystalline, particulate (e.g., uric acid crystals, asbestos, and alum), extracellular ATP, pore-forming toxins, as well as change in cellular environment, notably hypoxia<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. A salient unresolved issue is how various inflammasomes collectively are able to respond to such a wide spectrum of stimuli.</p><p id="Par5">The majority of transcripts transcribed from human or mouse genome are non-coding RNAs<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. Many are long non-coding RNAs (lncRNAs), which are defined as transcripts longer than 200 nucleotides but lacking significant protein coding capacity<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Thousands of lncRNAs have been identified to date<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref></sup>, yet only a small fraction of them are characterized. In the context of innate immunity, while a few lncRNAs have been implicated in regulation of inflammasome, including <italic>LincRNA-Gm4419</italic>, <italic>LincRNA-Cox2</italic>, and <italic>lincRNA-EPS</italic><sup><xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref></sup>, none have been reported to directly involve in inflammasome assembly.</p><p id="Par6">In the current study, we examine lncRNAs that associate with NLRP3 inflammasome in mouse macrophages and identify <italic>Neat1</italic> (nuclear enriched abundant transcript 1), a lncRNA transcribed from the multiple endocrine neoplasia locus (hence also known as <italic>Men</italic>). <italic>Neat1</italic> and its human ortholog <italic>NEAT1</italic> maintain the structural integrity of the paraspeckles<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, a specific type of nuclear bodies in the interchromatin space whose function remains poorly understood<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. <italic>NEAT1</italic> also regulates the expression of a group of chemokines and cytokines, including IL-6 and CXCL10, through the MAPK pathway<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Of note, the expression of <italic>Neat1</italic> is stimulated by many stimuli that also activate inflammasome, including infection of various viruses and some intracellular damages (e.g., ROS) that stabilize hypoxia-inducible factors (HIFs) and the tumor suppressor p53<sup><xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref></sup>.</p><p id="Par7">Here we find that <italic>Neat1</italic> promotes the activation of NLRP3, NLRC4, and AIM2 inflammasomes and enhances caspase-1 activation, cytokine production, and pyroptotic cell death. Mechanistically, <italic>Neat1</italic> binds to pro-caspase-1 and facilitates the assembly of inflammasomes, and also stabilizes the mature caspase-1 and increases caspase-1protease activity. In response to various inflammasome-activating signals, <italic>Neat1</italic> is released from paraspeckles and translocated to the cytoplasm to participate in inflammasome activity. Our findings establish a direct role for lncRNAs in regulating inflammasomes and suggest that <italic>Neat1</italic> may represent a downstream convergence point for inflammasome stimuli.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title><italic>Neat1</italic> enhances the activation of the NLRP3 inflammasome</title><p id="Par8">To investigate whether lncRNAs may regulate inflammasomes, we set out to identify lncRNAs that are associated with the NLRP3 inflammasome in murine immortalized bone marrow-derived macrophages (iBMDMs). We primed iBMDMs with lipopolysaccharides (LPS) and subsequently treated them with the potassium ionophore nigericin to activate the NLRP3 inflammasome. After treating these cells with UV to stabilize protein-RNA interactions, we immunoprecipitated NLRP3 inflammasomes using anti-NLRP3 antibody and analyzed the associated RNAs by high-throughput sequencing (GSE118722). Several non-coding RNAs were found to be enriched in NLRP3 inflammasomes, including those encoded by <italic>Ankrd52</italic>, <italic>Hipk3</italic>, <italic>Pou2f2</italic>, <italic>Neat1</italic>, <italic>Gm26917</italic>, <italic>Gm42418</italic>, <italic>Snord34</italic>, <italic>Junos</italic>, <italic>Gm26767</italic>, and <italic>Gm23935</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1a</xref>). Among them were four lncRNAs: <italic>Gm26917</italic>, <italic>Gm42418</italic>, <italic>Gm26767</italic>, and <italic>Neat1</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1a</xref>).</p><p id="Par9">To evaluate their effect on the NLRP3 inflammasome, we stably knocked down each of these four lncRNAs in iBMDMs using short hairpin RNA (shRNA). Knocking down <italic>Gm26917</italic>, <italic>Gm42418</italic>, or <italic>Gm26767</italic> lncRNAs had no effect on the NLRP3 inflammasome (data not shown). <italic>Neat1</italic> (Gene ID: 66961), is expressed in two isoforms, 3.2 kb <italic>Neat1_1</italic> (NR_003513.3, also known as <italic>Men epsilon</italic>) and 20 kb <italic>Neat1_2</italic> (NR_003513.3, also known as <italic>Men beta</italic>) (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1b</xref>). We knocked down <italic>Neat1_1</italic> and <italic>Neat1_2</italic> simultaneously using two independent shRNAs (#1 and #2; Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1b, c</xref>). Interestingly, the knockdown of total <italic>Neat1</italic> resulted in a strong reduction in oligomerization of ASC, indicative of impaired assembly of the inflammasome (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). This was accompanied by a noticeable reduction in the activation of caspase-1, processing of pro-interleukin 1β (pro-IL-1β) (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>), and secretion of mature IL-1β (Fig. <xref rid="Fig1" ref-type="fig">1b, c</xref>). We also knocked down <italic>Neat1_2</italic> alone with an isoform-specific shRNA (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1b, d</xref>), and observed an almost indistinguishable set of results (Fig. <xref rid="Fig1" ref-type="fig">1d, e</xref>). Conversely, we forced the expression of <italic>Neat1</italic>. <italic>Neat1_2</italic> is too long to be readily cloned and expressed. Therefore, we used the short variant <italic>Neat1_1</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1b</xref>). When <italic>Neat1_1</italic> was over-expressed in iBMDMs (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1h</xref>), LPS/nigericin-induced ASC aggregation, pro-caspase-1 cleavage, and IL-1β secretion were all increased (Figs. <xref rid="Fig1" ref-type="fig">1f, g</xref>).<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p><italic>Neat1</italic> enhances the activation of the NLRP3 inflammasome. <bold>a</bold>–<bold>c</bold> Control iBMDMs and iBMDMs devoid of <italic>Neat1</italic> by shRNA #1 (<bold>a</bold>, left and <bold>b</bold>) or #2 (<bold>a</bold>, right and <bold>c</bold>) were untreated, primed with LPS, or treated with nigericin after LPS priming. Whole cell lysates (WCL) and the supernatant (SN) and pellet (PE) fractions were analyzed by western blotting for indicated protein levels (<bold>a</bold>). Culture supernatant was analyzed by ELISA for IL-1β secretion (<bold>b</bold>, <bold>c</bold>). <bold>d</bold>–<bold>g</bold> iBMDMs devoid of Neat1_2 (<bold>d</bold>, <bold>e</bold>) or overexpressing Neat1_1 (<bold>f</bold>, <bold>g</bold>) and the corresponding controls were treated with or without LPS or nigericin as indicated, and analyzed for protein levels (<bold>d</bold>, <bold>f</bold>) and IL-1β secretion (<bold>e</bold>, <bold>g</bold>). <bold>h</bold>, <bold>i</bold> BMDMs from <italic>Neat1</italic> wild-type (<italic>Neat1</italic><sup>+/+</sup>) or knockout (<italic>Neat1</italic><sup>−/−</sup>) mice were primed with LPS and then stimulated with nigericin as indicated. Protein levels (<bold>h</bold>) and IL-1β secretion (<bold>i</bold>) were analyzed. In <bold>b</bold>, <bold>c</bold>, <bold>e</bold>, <bold>g</bold>, and <bold>i</bold>, data shown are mean ± SD (<italic>n</italic> = 4). ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig1_HTML.png"/></p></fig></p><p id="Par10">Knocking down total <italic>Neat1</italic> or <italic>Neat1_2</italic> alone, or overexpressing <italic>Neat1_1</italic>, did not alter the expression of NLRP3, ASC, pro-caspase-1, or pro-IL-1β (Fig. <xref rid="Fig1" ref-type="fig">1a, d, f</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1h</xref>), suggesting that <italic>Neat1</italic> promotes the assembly of the NLRP3 inflammasome rather than increasing the expression of its components or downstream targets. These changes in <italic>Neat1</italic> levels did not influence the secretion of TNF-α either (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1e–g, i</xref>), indicating a specific effect of <italic>Neat1</italic> on NLRP3 inflammasome-mediated cytokine production.</p><p id="Par11">To verify the stimulatory effect of <italic>Neat1</italic> on the NLRP3 inflammasome, we generated <italic>Neat1</italic> knockout (<italic>Neat1</italic><sup>−/−</sup>) mice on the C57BL/6 background using CRISPR/Cas9-based genome editing (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1j, k</xref>). Upon co-stimulation with nigericin and LPS, BMDMs derived from <italic>Neat1</italic><sup>−/−</sup> mice displayed much reduced caspase-1 activation and IL-1β secretion compared to BMDMs derived from wild-type (<italic>Neat1</italic><sup>+/+</sup>) mice (Fig. <xref rid="Fig1" ref-type="fig">1h, i</xref>), despite that both <italic>Neat1</italic><sup>+/+</sup> and <italic>Neat1</italic><sup>−/−</sup> BMDMs contained comparable mRNA and protein levels of NLRP3, ASC, pro-caspase-1, and pro-IL-1β (Fig. <xref rid="Fig1" ref-type="fig">1h</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1k</xref>) and showed similar TNF-α secretion (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1l</xref>). Moreover, <italic>Neat1</italic><sup>−/−</sup> and <italic>Neat1</italic><sup>+/+</sup> BMDMs also contained comparable levels of RelA/p65 (Fig. <xref rid="Fig1" ref-type="fig">1h</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1k</xref>), an upstream activator of the NLRP3 inflammasome, further underscoring the specific effect of <italic>Neat1</italic> on the NLRP3 inflammasome.</p><p id="Par12">Consistent with its role in the assembly of the NLRP3 inflammasomes, overexpression of <italic>Neat1_1</italic> increased the interactions of NLRP3 with both pro-caspase-1 and ASC (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1m</xref>). Therefore, <italic>Neat1</italic> promotes the formation of the NLRP3 inflammasome, leading to enhanced caspase-1 activation and IL-1β maturation.</p></sec><sec id="Sec4"><title><italic>Neat1</italic> enhances activation of NLRC4 and AIM2 inflammasomes</title><p id="Par13">To evaluate the generality of the effect of <italic>Neat1</italic>, we tested NLRC4 and AIM2 inflammasomes, both of which mediate the activation of caspase-1. Murine macrophages were primed with LPS and then stimulated with flagellin or poly(dA:dT) to active the NLRC4 or AIM2 inflammasome, respectively. iBMDMs devoid of both <italic>Neat1_1</italic> and <italic>Neat1_2</italic> (Fig. <xref rid="Fig2" ref-type="fig">2a, b</xref>), or <italic>Neat1_2</italic> alone (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2a, b</xref>), showed reduced activation of the NLRC4 and AIM2 inflammasomes, as indicate by a noticeable reduction in caspase-1 activation and IL-1β processing in response to flagellin and poly(dA:dT) treatment (Fig. <xref rid="Fig2" ref-type="fig">2a, b</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2a, b</xref>). Conversely, iBMDMs with forced expression of <italic>Neat1_1</italic> displayed augmented activation of both NLRC4 and AIM2 inflammasomes in response to these stimuli (Fig. <xref rid="Fig2" ref-type="fig">2c, d</xref>). Moreover, activation of NLRC4 and AIM2 inflammasomes was attenuated in <italic>Neat1</italic><sup>−/−</sup> BMDMs compared to <italic>Neat1</italic><sup>+/+</sup> BMDMs (Fig. <xref rid="Fig2" ref-type="fig">2e, f</xref>).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p><italic>Neat1</italic> enhances the activation of NLRC4 and AIM2 inflammasomes. <bold>a</bold>–<bold>d</bold> iBMDMs devoid of <italic>Neat1</italic> by shRNA #1 (<bold>a</bold>, <bold>b</bold>), iBMDMs overexpressing <italic>Neat1_1</italic> (<bold>c</bold>, <bold>d</bold>), and the corresponding control iBMDMs were primed with LPS, and then stimulated with flagellin (<bold>a</bold>, <bold>c</bold>) or poly(dA:dT) (<bold>b</bold>, <bold>d</bold>). WCL and SN were analyzed by western blotting. <bold>e</bold>, <bold>f</bold> BMDMs from <italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> mice were primed with LPS and then stimulated with flagellin (<bold>e</bold>) or poly(dA:dT) (<bold>f</bold>). WCL and SN were analyzed by western blotting. (<bold>g</bold>, <bold>h</bold>) Control iBMDMs and iBMDMs ectopically expressing <italic>Neat1_1</italic> were primed with LPS and then stimulated with flagellin (<bold>g</bold>) or poly(dA:dT) (<bold>h</bold>). Cell lysates were immunoprecipitated with normal rabbit IgG or ASC antibody. The samples were analyzed by western blotting as indicated. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig2_HTML.png"/></p></fig></p><p id="Par14">In addition, overexpression of <italic>Neat1_1</italic> enhanced not only the interactions of ASC with pro-caspase-1 and NLRC4 in flagellin-activated iBMDMs (Fig. <xref rid="Fig2" ref-type="fig">2g</xref>), but also the interactions of ASC with pro-caspase-1 and AIM2 in poly(dA:dT)-activated iBMDMs (Fig. <xref rid="Fig2" ref-type="fig">2h</xref>). Therefore, <italic>Neat1</italic> enhances the assembly and activation of diverse canonical inflammasomes that mediate the activation of caspase-1.</p></sec><sec id="Sec5"><title>Effect of <italic>Neat1</italic> on NLRP3 inflammasome is IL-6-independent</title><p id="Par15"><italic>Neat1</italic> could promote the expression of IL-6<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, a pro-inflammatory cytokine that stimulates immune response. However, in <italic>IL-6</italic><sup>−/−</sup> and <italic>IL-6</italic><sup>+/+</sup> BMDMs (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3a</xref>) treated with LPS and nigericin, both caspase-1 activation and IL-1β secretion occurred to a comparable extent (Fig. <xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3b</xref>). Moreover, siRNA-mediated knockdown of total <italic>Neat1</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3c, d</xref>), or <italic>Neat1_2</italic> alone (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3e</xref>), similarly inhibited caspase-1 activation and IL-1β secretion in <italic>IL-6</italic><sup>−/−</sup> and <italic>IL-6</italic><sup>+/+</sup> BMDMs (Fig. <xref rid="Fig3" ref-type="fig">3b–d</xref>). Thus, IL-6 does not appear to mediate the function of <italic>Neat1</italic> on the NLRP3 inflammasome.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>The effect of <italic>Neat1</italic> on the NLRP3 inflammasome activation is independent of IL-6. <bold>a</bold> BMDMs derived from <italic>IL-6</italic> wild-type (<italic>IL-6</italic><sup>+/+</sup>) or knockout (<italic>IL-6</italic><sup>−/−</sup>) mice were primed with LPS and then treated with nigericin. Protein levels in total cell lysates and supernatant fraction were analyzed by western blotting. <bold>b</bold>–<bold>d</bold><italic>IL-6</italic><sup>+/+</sup> or <italic>IL-6</italic><sup>−/−</sup> BMDMs were transfected with control siRNA (<bold>b</bold>–<bold>d</bold>), <italic>Neat1</italic> siRNA #1 (<bold>b</bold>), <italic>Neat1</italic> siRNA #2 (<bold>c</bold>), or <italic>Neat1_2</italic> siRNA (<bold>d</bold>). Twenty-four hours later, cells were stimulated with LPS and nigericin. WCL and SN of above cells were subjected to western blotting with indicated antibodies. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig3_HTML.png"/></p></fig></p></sec><sec id="Sec6"><title><italic>Neat1</italic> interacts with caspase-1 p20 domain</title><p id="Par16">Given that <italic>Neat1</italic> associates with, and promote the assembly of, the NLRP3 inflammasome in an IL-6-independent manner, we evaluated which component(s) of the NLRP3 inflammasome interacts with <italic>Neat1</italic>. NLRP3, ASC, and pro-caspase-1 were immunoprecipitated by their specific antibodies from lysates of murine iBMDMs at different stages of stimulation: no stimulation, primed with LPS only, and primed with LPS followed by stimulation with nigericin. Total <italic>Neat1</italic> and <italic>Neat1_2</italic> were found in pro-caspase-1 immunoprecipitates from cells of all three stages, but in NLRP3 and ASC immunoprecipitates only from cells that are activated by both LPS and nigericin (Fig. <xref rid="Fig4" ref-type="fig">4a–c</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4a–c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p><italic>Neat1</italic> interacts with caspase-1 p20 domain. <bold>a</bold>–<bold>c</bold> Cell lysates of normal iBMDMs, LPS-primed iBMDMs or LPS-nigericin-co-stimulated iBMDMs were incubated with normal rabbit IgG (<bold>a</bold>–<bold>c</bold>), NLRP3 antibody (<bold>a</bold>), ASC antibody (<bold>b</bold>), or caspase-1 antibody (<bold>c</bold>) for RIP. The immunoprecipitates were analyzed by real-time RT-PCR to exam enrichment efficiency of <italic>Neat1</italic> and by Western blotting for protein levels. <bold>d</bold> Cell lysates of normal, LPS-primed, or LPS-nigericin-co-stimulated iBMDMs were incubated with biotin-labeled <italic>Neat1</italic> sense or antisense DNA probes immobilized on beads. The precipitated samples were analyzed by real-time RT-PCR for <italic>Neat1</italic> contents, and by western blotting for indicated protein levels. <bold>e</bold> In vitro transcribed biotin-labeled <italic>Neat1_1</italic> was incubated with lysates extracted from 293T cells expressing Flag-tagged wild-type pro-caspase-1, CARD, p20, or p10 for 3 h. The input and biotin pull-down samples were then carried out to western blotting. <bold>f</bold> In vitro transcribed biotin-labeled <italic>Neat1_1</italic> was incubated with lysates extracted from 293T cells expressing Flag-tagged wild-type pro-caspase-1 or the indicated deletion mutants for 3 h. The input and biotin pull-down samples were analyzed by western blotting. In <bold>a</bold>, data shown are mean ± SD (<italic>n</italic> = 5). In <bold>b</bold> and <bold>d</bold>, data shown are mean ± SD (<italic>n</italic> = 3). In <bold>c</bold>, data shown are mean ± SD (<italic>n</italic> = 6). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig4_HTML.png"/></p></fig></p><p id="Par17">In a complementary approach, we pulled down <italic>Neat1</italic> from cell lysates using biotinylated <italic>Neat1</italic> antisense DNA probes, and analyzed the presence of NLRP3 inflammasome components in the pull-down samples. This again revealed that pro-caspase-1 bound to <italic>Neat1</italic> in cells of all three stages, whereas ASC and NLRP3 bound to <italic>Neat1</italic> only in cells treated with both LPS and nigericin (Fig. <xref rid="Fig4" ref-type="fig">4d</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4d</xref>). Thus, <italic>Neat1</italic> likely interacts with pro-caspase-1 constitutively and directly, and with NLRP3 and ASC inducibly and indirectly when these components are incorporated into the inflammasome together with pro-caspase-1.</p><p id="Par18">Likewise, during the activation of the NLRC4 and AIM2 inflammasomes, <italic>Neat1</italic> bound to pro-caspase-1 directly in cells of all stages: non-stimulated, LPS-primed, and LPS-primed followed by flagellin or poly(dA:dT) stimulation, whereas <italic>Neat1</italic> bound to NLRC4/AIM2 and ASC only upon flagellin-dependent NLRC4 inflammasome activation or poly(dA:dT)-dependent AIM2 inflammasome activation (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4e–h</xref>).</p><p id="Par19">Upon activation, caspase-1 is processed to the mature subunits p20 and p10. We observed that more p20 than p10 subunits were pulled down by the <italic>Neat1</italic> antisense DNA probes (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). This observation suggested that <italic>Neat1</italic> may directly associate with the p20 subunit of the mature caspase-1 or the region corresponding to p20 on pro-caspase-1, and indirectly with the p10 subunit within the assembled mature caspase-1 hetero-tetramer. To verify this, we generated a panel of caspase-1 deletion mutations, each tagged with the Flag epitope (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5a, b</xref>). These mutants, as well as full-length pro-caspase-1, were expressing in 293T cells, and the cell lysates were incubated with biotin-labeled <italic>Neat1_1</italic>. This assay showed that <italic>Neat1_1</italic> bound to pro-caspase-1 and the p20 region, but not the caspase recruitment domain (CARD) or the p10 region (Fig. <xref rid="Fig4" ref-type="fig">4e</xref>). Furthermore, deletion of the p20 region (Δp20), but not the deletion of the CARD (ΔCARD) or the p10 region (Δp10), abolished the interaction with <italic>Neat1_1</italic> (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>). Therefore, the p20 region of pro-caspase-1 is both sufficient and necessary for the interaction with <italic>Neat1</italic>, and this interaction persists upon caspase-1 activation.</p><p id="Par20">To map the caspase-1-binding region on <italic>Neat1</italic>, we performed NLRP3 CLIP-seq peaks analysis. A strong and specific peak in the 5′ region of <italic>Neat1_1</italic> and <italic>Neat1_2</italic>, along with some other weak peaks in the rest of <italic>Neat1_1</italic>, was identified (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5c</xref>), consistent with binding of total <italic>Neat1</italic> and <italic>Neat1_2</italic> with the NLRP3 inflammasome. We generated three <italic>Neat1_1</italic> segments according to the CLIP-seq analysis (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5c</xref>), and incubated each of them with HA-tagged pro-caspase-1. Only full-length <italic>Neat1_1</italic> and segment 1, which contained the 5′ 1 kb region, could pull down HA-tagged pro-caspase-1 (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5d</xref>), suggesting that <italic>Neat1</italic> binds with pro-caspase-1 via its 5′ region.</p></sec><sec id="Sec7"><title><italic>Neat1</italic> stabilizes the caspase-1 hetero-tetramers</title><p id="Par21">The active caspase-1, an α<sub>2</sub>β<sub>2</sub> hetero-tetramer formed by two p10 subunits and two p20 subunits<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, is turned over by the ubiquitin-proteasome pathway<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. The hetero-tetramer is also unstable and readily dissociates<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. <italic>Neat1_1</italic> did not affect the ubiquitination of either pro-caspase-1 or the p20 subunit (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6a</xref>). Instead, <italic>Neat1</italic> increased the interaction between p20 and p10 (Fig. <xref rid="Fig5" ref-type="fig">5a, b</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6b, c</xref>), suggesting that <italic>Neat1</italic> stabilizes the (p20:p10)<sub>2</sub> hetero-tetramer. Mature caspase-1 can also exist as a transient (p33:p10)<sub>2</sub> species, where p33 contains both the CARD and p20 regions<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. Of note, <italic>Neat1_1</italic> could also increase the interaction between p33 and p10 (Fig. <xref rid="Fig5" ref-type="fig">5c, d</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5d, e</xref>). Therefore, <italic>Neat1</italic> stabilizes the subunit–subunit interactions of mature caspase-1 hetero-tetramers. Consistently, caspase-1 activity was significantly reduced in <italic>Neat1</italic><sup>−/−</sup> BMDMs compared to <italic>Neat1</italic><sup>+/+</sup> BMDMs upon the formation of NLRP3, NLRC4, or AIM2 inflammasomes (Fig. <xref rid="Fig5" ref-type="fig">5e</xref>), while caspase-1 activity was strongly increased in <italic>Neat1_1</italic>-overexpressing cells compared to control cells upon the formation of these canonical inflammasomes (Fig. <xref rid="Fig5" ref-type="fig">5f</xref>). Therefore, <italic>Neat1</italic> strengthens the inter-subunit interactions within mature caspase-1 and augments the protease activity.<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p><italic>Neat1</italic> stabilizes the caspase-1 hetero-tetramers and increases caspase-1 activity. <bold>a</bold>–<bold>d</bold> 293T cells were infected with lentiviruses expressing control RNA or <italic>Neat1_1</italic> and then co-transfected with Flag-p20 and HA-p10 (<bold>a</bold>, <bold>b</bold>) or Flag-p33 and HA-p10 (<bold>c</bold>, <bold>d</bold>). Cell lysates were incubated with anti-Flag mAb (M2) beads. Input samples and pull-down products were subjected to western blotting (<bold>a</bold>, <bold>c</bold>). Relative ratios of HA-p10 pulled down by Flag-p20 (<bold>b</bold>) or Flag-p33 (<bold>d</bold>) were shown in histogram, based on the data of three independent replication experiments. <bold>e</bold><italic>Neat1</italic><sup>+/+</sup> and <italic>Neat1</italic><sup>−/−</sup> BMDMs were primed with LPS and then activated with nigericin, flagellin, or poly(dA:dT). Mature caspase-1 activity was measured. <bold>f</bold> Control or <italic>Neat1_1</italic> overexpressing iBMDMs were primed with LPS and then activated with nigericin, flagellin, or poly(dA:dT). Mature caspase-1 activity were measured. In <bold>b</bold>, <bold>d</bold>, <bold>e</bold> and <bold>f</bold>, data shown are mean ± SD (<italic>n</italic> = 3). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig5_HTML.png"/></p></fig></p></sec><sec id="Sec8"><title><italic>Neat1</italic> promotes caspase-1-dependent pyroptosis</title><p id="Par22">In addition to cytokine secretion, activation of caspase-1 by canonical inflammasomes results in pyroptosis<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. We observed significant cell death among LPS and nigericin co-stimulated iBMDMs, but not untreated or LPS-primed iBMDMs, as shown by propidium iodide-positive staining and lactate dehydrogenase (LDH) release. Overexpression of <italic>Neat1_1</italic> noticeably augmented LPS/nigericin-induced pyroptosis (by ~120%; Fig. <xref rid="Fig6" ref-type="fig">6a, b</xref>), whereas <italic>Neat1</italic> silencing dramatically reduced pyroptosis (by ~80%; Fig. <xref rid="Fig6" ref-type="fig">6c, d</xref>). Likewise, <italic>Neat1</italic> knockout rendered BMDMs high resistant to pyroptosis (reduced by ~70%; Fig. <xref rid="Fig6" ref-type="fig">6e, f</xref>). Therefore, <italic>Neat1</italic> promotes caspase-1-dependent pyroptotic cell death.<fig id="Fig6"><label>Fig. 6</label><caption xml:lang="en"><p><italic>Neat1</italic> promotes caspase-1-dependent pyroptosis. <bold>a</bold>–<bold>f</bold><italic>Neat1_1</italic>-overexpressing iBMDMs (<bold>a</bold>, <bold>b</bold>), <italic>Neat1</italic>-knockdown iBMDMs (<bold>c</bold>, <bold>d</bold>), <italic>Neat1</italic><sup>−/−</sup> BMDMs (<bold>e</bold>, <bold>f</bold>), and the corresponding control cells were primed with LPS and then stimulated with nigericin. Cells were stained with PI and analyzed under microscope (<bold>a</bold>, <bold>c</bold>, and <bold>e</bold>). Percentages of pyroptotic cells were measured by LDH release into supernatants (<bold>b</bold>, <bold>d</bold>, and <bold>f</bold>). In <bold>a</bold>, <bold>c</bold>, and <bold>e</bold>, the bar graph indicates 300 μm. In <bold>b</bold>, <bold>d</bold>, and <bold>f</bold>, data shown are mean ± SD (<italic>n</italic> = 4). ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig6_HTML.png"/></p></fig></p></sec><sec id="Sec9"><title><italic>Neat1</italic> is exported to cytoplasm upon inflammasome activation</title><p id="Par23">Murine <italic>Neat1</italic> and its human ortholog are highly abundant lncRNAs that are mainly localized to the nucleus of unstressed cells<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, while assembly of various canonical inflammasomes occurs in the cytoplasm<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. We found that, upon the stimulation of LPS and nigericin, the levels of total <italic>Neat1</italic> or the <italic>Neat1_2</italic> isoform remained unchanged (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7a</xref>). To understand how <italic>Neat1</italic> participates in the inflammasome activation, we examined the presence of <italic>Neat1</italic> in the cytoplasmic fraction and culture medium of cells treated under different conditions. Compared with untreated or LPS-primed iBMDMs, LPS and nigericin co-stimulated iBMDMs contained more <italic>Neat1</italic> in the cytoplasm (~8.5% versus ~1%; Fig. <xref rid="Fig7" ref-type="fig">7a</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7b</xref>). Moreover, consistent with the increased pyroptosis, LPS and nigericin co-stimulated iBMDMs also released more <italic>Neat1</italic> into the culture medium (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7c</xref>). Similarly, more <italic>Neat1</italic> was released from nucleus to cytoplasm in LPS/flagellin- or LPS/poly(dA:dT)-treated iBMDMs compared to untreated or LPS-primed iBMDMs (Fig. <xref rid="Fig7" ref-type="fig">7b, c</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7d, e</xref>). Additionally, we treated iBMDMs with LPS and 2DG to stimulate the formation of Nlrp1b inflammasome. This also led to the translocation of <italic>Neat1</italic> to the cytoplasm (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7f, g</xref>). These observations suggest that <italic>Neat1</italic> is released from nucleus to the cytoplasm during the activation of the NLRP3, NLRC4, AIM2, or Nlrp1b inflammasome.<fig id="Fig7"><label>Fig. 7</label><caption xml:lang="en"><p><italic>Neat1</italic> is exported from nucleus to cytoplasm in response to inflammasome-activating stimuli. <bold>a</bold>–<bold>c</bold> Untreated iBMDMs (<bold>a</bold>–<bold>c</bold>), LPS-primed iBMDMs (<bold>a</bold>–<bold>c</bold>), nigericin-activated iBMDMs (<bold>a</bold>), flagellin-activated iBMDMs (<bold>b</bold>), or poly(dA:dT)-activated iBMDMs (<bold>c</bold>) were subjected to fractionation into cytoplasmic and nuclear extracts. Cytoplasmic RNA was analyzed for the <italic>Neat1</italic> expression by real-time RT-PCR. <bold>d</bold> The subcellular co-localization of <italic>Neat1</italic> (green) and ASC (purple) in untreated, LPS-primed or LPS-nigericin-co-stimulated iBMDMs was analyzed by RNA-FISH and IF. In <bold>d</bold>, the bar graph indicates 5 μm. In <bold>a</bold>, <bold>b</bold>, and <bold>c</bold>, data shown are mean ± SD (<italic>n</italic> = 3). *<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig7_HTML.png"/></p></fig></p><p id="Par24">To corroborate the observations, we performed RNA fluorescence in situ hybridization (RNA-FISH) to assess the cellular localization of <italic>Neat1</italic>. Among untreated or LPS-primed iBMDMs, <italic>Neat1</italic> remained in the nucleus while ASC was diffusely localized in the cytoplasm (Fig. <xref rid="Fig7" ref-type="fig">7d</xref>). However, in LPS and nigericin co-stimulated iBMDMs where ASC became polymerized, a portion of <italic>Neat1</italic> was released to the cytoplasm and became colocalized with ASC (Fig. <xref rid="Fig7" ref-type="fig">7d</xref>), further supporting the notion that the nuclear export of <italic>Neat1</italic> is induced in activated cells to facilitate inflammasomes formation.</p></sec><sec id="Sec10"><title>Perturbation of paraspeckles leads to the release of <italic>Neat1</italic></title><p id="Par25"><italic>Neat1</italic> is concentrated in paraspeckles and is an essential architectural component of these nuclear bodies<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. To examine how LPS and nigericin co-stimulation may induce <italic>Neat1</italic> nuclear export, we examined levels of three main paraspeckle proteins, Nono, Pspc1, and Sfpq<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Compared with control or LPS-treated iBMDMs, Pspc1 and the short isoform of Sfpq (Sfpq-S) declined in their abundance in LPS and nigericin co-treated iBMDMs, while the levels of Nono and the long isoform of Sfpq (Sfpq-L) remained unchanged (Fig. <xref rid="Fig8" ref-type="fig">8a</xref>). Levels of Pspc1 and Sfpq-S were also decreased in iBMDMs activated by flagellin or poly(dA:dT) (Fig. <xref rid="Fig8" ref-type="fig">8b, c</xref>). In addition, levels of Pspc1 declined in 2DG-activated iBMDMs (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8a</xref>). Accordingly, the size and number of paraspeckles were dramatically reduced in LPS and nigericin co-stimulated iBMDMS compared to untreated or LPS-primed iBMDMs (Fig. <xref rid="Fig8" ref-type="fig">8d</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8b, c</xref>). Consistently, the interaction of Nono with Pspc1 and Sfpq was reduced in response to the activation of the NLRC4, AIM2, and Nlrp1b inflammasome (Fig. <xref rid="Fig8" ref-type="fig">8e, f</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8d</xref>). All above results claim that activation of various inflammasomes weakens assembly of paraspeckles, which store <italic>Neat1</italic> in nucleus.<fig id="Fig8"><label>Fig. 8</label><caption xml:lang="en"><p><italic>Neat1</italic> is released from nuclear paraspeckles into cytoplasm during inflammasome activation. <bold>a</bold>–<bold>c</bold> Cell lysates of untreated iBMDMs (<bold>a</bold>–<bold>c</bold>), LPS-primed iBMDMs (<bold>a</bold>–<bold>c</bold>), nigericin-activated iBMDMs (<bold>a</bold>), flagellin-activated iBMDMs (<bold>b</bold>), or poly(dA:dT)-activated iBMDMs (<bold>c</bold>) were analyzed by Western blotting. <bold>d</bold> Colocation of paraspeckle proteins, Sfpq (green), and Pspc1 (red) were assayed by immunostaining. The location of paraspeckles (yellow) was obtained by merging two signals of Sfpq and Pspc1. The position of the nucleus is shown in the bright-field image. <bold>e</bold>, <bold>f</bold> Interactions among paraspeckle components in untreated iBMDMs (<bold>e</bold>, <bold>f</bold>), LPS-primed iBMDMs (<bold>e</bold>, <bold>f</bold>), flagellin-activated iBMDMs (<bold>e</bold>), or poly(dA:dT)-activated iBMDMs (<bold>f</bold>) were analyzed by co-immunoprecipitation assay. <bold>g</bold>, <bold>h</bold> iBMDMs infected with lentiviruses expressing control, Pspc1, Sfpq, or Nono shRNA were analyzed for the cytoplasmic and nuclear levels of <italic>Neat1</italic> and <italic>Neat1_2</italic>. Percentages of cytoplasmic <italic>Neat1</italic> or <italic>Neat1_2</italic> among total <italic>Neat1</italic> or <italic>Neat1_2</italic> RNA were shown in <bold>h</bold>. In <bold>d</bold>, the bar graph indicates 10 μm. In <bold>g</bold> and <bold>h</bold>, data shown are mean ± SD (<italic>n</italic> = 3). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig8_HTML.png"/></p></fig></p><p id="Par26">To verify that the perturbation of paraspeckles results in the release of <italic>Neat1</italic> into the cytoplasm, we knocked down Nono, Pspc1, and Sfpq individually (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8e, f</xref>). In each case, the nuclear export of both total <italic>Neat1</italic> and <italic>Neat_2</italic> was observed, and a substantial fraction of <italic>Neat1</italic> (~15–20%) was found in the cytoplasm (Fig. <xref rid="Fig8" ref-type="fig">8g, h</xref>). Therefore, stimuli, that activate various inflammasomes, disrupt paraspeckles leading to the translocation of <italic>Neat1</italic> to the cytoplasm, where <italic>Neat1</italic> influences the assembly of inflammasomes.</p></sec><sec id="Sec11"><title><italic>Neat1</italic> mediates the effect of HIF-2α on inflammasomes</title><p id="Par27">The expression of <italic>Neat1</italic> is induced by infection of viruses (e.g., influenza virus and herpes simplex virus)<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup>, and is also regulated by the tumor suppressor p53<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, a central sentinel for various internal and external stresses<sup><xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>. In addition, hypoxia, which promotes inflammation via HIF-1α-mediated induction of NLRP3 and IL-1β<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, can induce <italic>Neat1</italic> through HIF-2α-mediated transcriptional activation<sup><xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>. Thus, <italic>Neat1</italic> may function as a stress sensor for associated inflammasomes. To test this possibility, we investigated the role of <italic>Neat1</italic> in hypoxia-mediated activation of the NLRP3 inflammasome. iBMDMs cultured under hypoxic conditions exhibited increased levels of <italic>Neat1</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">9a</xref>), HIF-1α, HIF-2α, p65, NLRP3, and IL-1β (Fig. <xref rid="Fig9" ref-type="fig">9a</xref>), which was accompanied by enhanced NLRP3 inflammasome formation, caspase-1 activation, and IL-1β secretion (Fig. <xref rid="Fig9" ref-type="fig">9a</xref>). However, knockout of <italic>Neat1</italic> not only reduced the activation of NLRP3 inflammasome under normoxic conditions, but also effectively prevented the increase of inflammasome activation under hypoxic conditions (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">9b</xref>), underscoring a critical role for <italic>Neat1</italic> in hypoxia-induced NLRP3 inflammasome activation. In addition, activation of NLRC4 and AIM2 inflammasomes was also increased under hypoxic conditions, along with increased expression of HIF-1α, HIF-2α, and IL-1β (Fig. <xref rid="Fig9" ref-type="fig">9b, c</xref>). Knocking down either HIF-1α (Fig. <xref rid="Fig9" ref-type="fig">9d, f, h</xref>) or HIF-2α (Fig. <xref rid="Fig9" ref-type="fig">9e, g, i</xref>) reduced hypoxia-induced caspase-1 activation and IL-1β maturation under the condition of NLRP3, NLRC4, or AIM2 inflammasome activation (Fig. <xref rid="Fig9" ref-type="fig">9d–i</xref>), indicating that both HIF-1α and HIF-2α mediate the effect of hypoxia on canonical inflammasomes. HIF-1α knockdown, but not HIF-2α knockdown, reduced the activation of diverse inflammasomes in iBMDMs devoid of <italic>Neat1</italic> (Fig. <xref rid="Fig9" ref-type="fig">9d–i</xref>), which claims that Neat1 silencing could efficiently block the effect of HIF-2α, but not HIF-1α, on inflammasomes activation. These results suggest that hypoxia-induced activation of the NLRP3, NLRC4, and AIM2 inflammasomes and associated inflammatory responses are in part due to HIF-2α-mediated upregulation of <italic>Neat1</italic>.<fig id="Fig9"><label>Fig. 9</label><caption xml:lang="en"><p><italic>Neat1</italic> mediates the effect of HIF-2α on inflammasomes under hypoxic condition. <bold>a</bold>–<bold>c</bold> iBMDMs cultured under normoxic or hypoxic conditions were untreated (<bold>a</bold>–<bold>c</bold>), primed with LPS (<bold>a</bold>–<bold>c</bold>,or co-stimulated with LPS and nigericin (<bold>a</bold>), flagellin (<bold>b</bold>), or poly(dA:dT) (<bold>c</bold>). WCL (<bold>a</bold>–<bold>c</bold>), SN (<bold>a</bold>–<bold>c</bold>), and PE (<bold>a</bold>) were subjected to western blotting. <bold>d</bold>–<bold>i</bold> Control (<bold>d</bold>–<bold>i</bold>), HIF-1α-silenced (<bold>d</bold>, <bold>f</bold>, and <bold>h</bold>), HIF-2α-silenced (<bold>e</bold>, <bold>g</bold> and <bold>i</bold>), <italic>Neat1</italic>-silenced (<bold>d</bold>–<bold>i</bold>), HIF-1α-<italic>Neat1</italic>-double-silenced (<bold>d</bold>, <bold>f</bold> and <bold>h</bold>), or HIF-2α-<italic>Neat1</italic>-double-silenced (<bold>e</bold>, <bold>g</bold> and <bold>i</bold>) iBMDMs were cultured under hypoxic conditions and primed with LPS, followed by stimulation with nigericin (<bold>d</bold>, <bold>e</bold>), flagellin (<bold>f</bold>, <bold>g</bold>), or poly(dA:dT) (<bold>h</bold>, <bold>i</bold>). WCL and SN were analyzed by western blotting. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig9_HTML.png"/></p></fig></p></sec><sec id="Sec12"><title>Loss of <italic>Neat1</italic> reduces inflammation in vivo</title><p id="Par28">To investigate the effect of <italic>Neat1</italic> in vivo, we used an NLRP3 inflammasome-mediated, IL-1-dependent mouse peritonitis model induced by the aluminum salt alum<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. We intraperitoneal (i.p.) injected alum in <italic>Neat1</italic><sup>+/+</sup> and <italic>Neat1</italic><sup>−/−</sup> mice to induce peritonitis, and assayed IL-1β in the lavage fluid. A significant reduction of IL-1β secretion in the lavage fluid was observed in <italic>Neat1</italic><sup>−/−</sup> mice compared to <italic>Neat1</italic><sup>+/+</sup> mice (by ~67%; Fig. <xref rid="Fig10" ref-type="fig">10a</xref>). Moreover, collected peritoneal exudate cells (PECs) and analyzed alum-induced recruitment of inflammatory cells by flow cytometry (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">10a</xref>). The number of total PECs recruited upon alum challenge was markedly decreased by 58% in <italic>Neat1</italic><sup>−/−</sup> mice (Fig. <xref rid="Fig10" ref-type="fig">10b</xref>). Alum-induced recruitment of neutrophils and Ly6C<sup>+</sup> monocytes was also strongly inhibited in the <italic>Neat1</italic><sup>−/−</sup> mice (Fig. <xref rid="Fig10" ref-type="fig">10c, d</xref>).<fig id="Fig10"><label>Fig. 10</label><caption xml:lang="en"><p>Loss of <italic>Neat1</italic> impairs alum-induced peritoneal inflammation and attenuates flagellin-induced lung inflammation in vivo. <bold>a</bold> IL-1β content in the lavage fluid from <italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> mice 12 h after PBS or alum injection. <bold>b</bold> Absolute numbers of <italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> PECs recovered 12 h after PBS or alum injection. <bold>c</bold>, <bold>d</bold> Absolute numbers of neutrophils (<bold>c</bold>) and Ly6C<sup>+</sup> monocytes (<bold>d</bold>) exuded to the peritoneum 12 h after PBS or alum injection. <bold>e</bold> IL-1β content in the BALF from <italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> mice 12 h after isotonic saline or flagellin intranasal instillation. <bold>f</bold> Absolute numbers of <italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> PECs recovered 12 h after isotonic saline or flagellin intranasal instillation. <bold>g</bold>, <bold>h</bold> Absolute numbers of neutrophils (<bold>g</bold>) and Ly6C<sup>+</sup> monocytes (<bold>h</bold>) exuded to the lung 12 h after isotonic saline or flagellin intranasal instillation. In <bold>a</bold>–<bold>h</bold>, data shown are mean ± SD (<italic>n</italic> = 6). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001, two-tailed <italic>t</italic>-test. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_9482_Fig10_HTML.png"/></p></fig></p><p id="Par29">To evaluate the role of <italic>Neat1</italic> on NLRC4 inflammasome activation in vivo, we used a mouse model of flagellin-induced pneumonia. <italic>Neat1</italic><sup>+/+</sup> and <italic>Neat1</italic><sup>−/−</sup> mice were intranasally instilled with TurboFect reagent and flagellin to induce pneumonia. We found that IL-1β secretion in bronchoalveolar lavage fluid (BALF) was decreased by 70% in flagellin-challenged <italic>Neat1</italic><sup>−/−</sup> mice compared to flagellin-challenged <italic>Neat1</italic><sup>+/+</sup> mice (Fig. <xref rid="Fig10" ref-type="fig">10e</xref>). We also analyzed bronchoalveolar lavage cells (BALCs) and flagellin-induced recruitment of inflammatory cells by flow cytometry (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">10b</xref>). The total number of BALCs recruited upon flagellin challenge was decreased by 70% in <italic>Neat1</italic><sup>−/−</sup> mice (Fig. <xref rid="Fig10" ref-type="fig">10f</xref>). Furthermore, flagellin-induced recruitment of neutrophils and Ly6C<sup>+</sup> monocytes was strongly decreased in <italic>Neat1</italic><sup>−/−</sup> mice (Fig. <xref rid="Fig10" ref-type="fig">10g, h</xref>).</p><p id="Par30">The overt defects of <italic>Neat1</italic><sup>−/−</sup> mice in alum-induced peritoneal inflammation and flagellin-induced lung inflammation emphasize an important function for <italic>Neat1</italic> in the activations of the canonical inflammasomes, the subsequent accumulation of immune cells and the associated symptoms in vivo.</p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p id="Par31">Proper control of inflammasome assembly and caspase-1 activation permits effective antimicrobial and inflammatory responses while avoiding tissue damage. Yet, how these supramolecular assemblies are regulation remains incompletely defined. LncRNAs are increasingly recognized as important regulators in different biological settings, but few lncRNAs are implicated in innate immunity<sup><xref ref-type="bibr" rid="CR57">57</xref>–<xref ref-type="bibr" rid="CR60">60</xref></sup>. The current work reveals that the lncRNA <italic>Neat1</italic> plays a critical role in regulating various caspase-1-associated canonical inflammasomes including NLRC4, AIM2, and especially NLRP3 inflammasomes. <italic>Neat1</italic> promotes the assembly of inflammasomes, and also stabilizes the mature caspase-1 tetramers, (p20:p10)<sub>2</sub>, and (p33:p10)<sub>2</sub>, and increases their protease activity. Thus, <italic>Neat1</italic> is likely a previously unanticipated RNA component that enables the assembly of these largely proteinaceous signaling platforms to facilitate the recruitment, maturation, and stabilization of caspase-1 in activated macrophages. The ability of <italic>Neat1</italic> to directly regulate inflammasomes provides a notable example for the role of lncRNAs in regulating large multimeric protein complexes in the cytoplasm.</p><p id="Par32">The assembly of inflammasomes requires a common priming event, such as LPS-induced activation of TLRs, which induces the expression of NLRP3 and pro-IL-1β<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. However, the NLRC4, AIM2, and especially NLRP3 inflammasomes are versatile inflammasome, collectively responding to a wide range of stimuli<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR61">61</xref>–<xref ref-type="bibr" rid="CR64">64</xref></sup>. It remains unclear whether these stimuli also employ a general mechanism to modulate inflammasomes. Of note, the expression of <italic>Neat1</italic> is highly regulated by various signals, including those that activates the tumor suppressor p53 (refs. <sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>). Moreover, hypoxia is a key physiological stressor present within both normal and tumor microenvironments<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> and a critical determinant of the immune response. Here we show that <italic>Neat1</italic> links the effect of hypoxia with the activation of NLRP3, NLRC4, and AIM2 inflammasomes. Both human <italic>NEAT1</italic> and murine <italic>Neat1</italic> are thought to maintain the structural integrity of the paraspeckles<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, the function of which remains unclear. We find that the paraspeckles are disrupted in response to various inflammasome-activating signals, leading to the release of <italic>Neat1</italic> and subsequent translocation to the cytoplasm, implying that paraspeckles may serve as a storage depot for <italic>Neat1</italic>. Therefore, the upregulation and translocation of <italic>Neat1</italic> may be a converging event leading to the activation of the various caspase-1-associated canonical inflammasomes by a wide range of stimuli, underscoring a common mechanism for the assembly of these inflammation signaling platforms. In addition, our finding, along with previous observation that ASC and NLRP3 are recruited from other cellular components to mitochondria and associated endoplasmic reticulum membranes upon both priming and activation processes<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>, also highlights the trafficking of inflammasome components as a major mechanism for the regulation of inflammasome activity.</p><p id="Par33">Finally, by generating <italic>Neat1</italic> knockout mice and analyzing their response to alum-induced peritoneal inflammation and flagellin-induced lung inflammation, we demonstrate that <italic>Neat1</italic> enhances the activation of NLRP3 and NLRC4 inflammasomes and promotes pyroptosis in vivo (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">11</xref>). Therefore, <italic>Neat1</italic> may represent a therapeutic target for inflammasome-associated diseases such as gout and autoinflammatory syndromes.</p></sec><sec id="Sec14" sec-type="methods"><title>Methods</title><sec id="Sec15"><title>Antibodies and reagents</title><p id="Par34">Antibodies used for western bloting included anti-IL-1β (R&amp;D Systems, 1:1000, AF-401-NA), anti-HIF-2α (R&amp;D Systems, 1:1000, AF2997), anti-NLRP3 (Adipogen, 1:1000, AG-20B-0014), anti-ASC (Adipogen, 1:1000, AG-25B-0006), anti-caspase-1 (p20) (Adipogen, 1:1000, AG-20B-0042), anti-caspase-1 (p10) (Adipogen, 1:1000, AG-20B-0044), anti-p65 (Cell Signaling Technology, 1:1000, 8242), anti-HIF-1α (Cell Signaling Technology, 1:1000, 14179), anti-AIM2 (Cell Signaling Technology, 1:1000, 13095), anti-IL-6 (Cell Signaling Technology, 1:1000, 12912), anti-Actin (CMC-TAG, 1:2000, AT0009), anti-FLAG (Sigma-Aldrich, 1:2000, F3165), anti-Pspc1 (Santa Cruz, 1:200, sc-374181), anti-Sfpq (Santa Cruz, 1:200, sc-271796), anti-Nono (ABclonal, 1:500, A5282), anti-NLRC4 (ABclonal, 1:500, A7382), anti-histone H2A (abcam, 1:1000, ab177308), HRP-linked anti-rabbit IgG (Cell Signaling Technology, 1:2000, 7074), HRP-linked anti-mouse IgG (Cell Signaling Technology, 1:2000, 7076), HRP-linked anti-goat IgG (Santa Cruz, 1:1000, sc-2354). Antibodies used for immunoprecipitation included anti-NLRP3 (Cell Signaling Technology, 1:200, 15101), anti-caspase-1 (p20) (Adipogen, 1:200, AG-20B-0042), anti-ASC (Adipogen, 1:200, AG-25B-0006), anti-Nono (ABclonal, 1:50, A5282), normal rabbit IgG (Cell Signaling Technology, 1:200, 2729), normal mouse IgG (Santa Cruz, 1:80, sc-2025). Anti-ASC (Santa Cruz, 1:50, sc-22514), anti-Pspc1 (mouse IgG, Santa Cruz, 1:50, sc-374181), anti-Sfpq (mouse IgG, Santa Cruz, 1:50, sc-271796), anti-Sfpq (rabbit IgG, Proteintech, 1:50, 15585-1-AP), anti-Nono (rabbit IgG, ABclonal, 1:50, A5282), Alexa fluor 488 donkey anti-rabbit IgG(H + L) (Life Technologies, 1:1000, A21206), Alexa fluor 568 donkey anti-mouse IgG(H + L) (Life Technologies, 1:1000, A10037), and Alexa fluor 647 donkey anti-rabbit IgG(H + L) (Life Technologies, 1:1000, A31573) were used for immunofluorescence. PerCP-Cy<sup>TM</sup>5.5 anti-mouse CD11b (BD Biosciences, 1:1000, 550993), APC anti-mouse Ly-6G (BD Biosciences, 1:1000, 560599), and PE anti-mouse Ly-6C (BD Biosciences, 1:1000, 560592) were used for flow cytometry. LPS, nigericin, flagellin, and poly(dA:dT) were purchased from Invivogen; Lipofectamine 2000 Transfection Reagent was from Invitrogen; DOTAP Liposomal Transfection Reagent was from Roche; puromycin, MG132, propidium iodide, and 2-deoxy-D-Glucose were from Solarbio; proteinase K and RiboLock RNase Inhibitor were from ThermoFisher Scientific; and Igepal CA-630 was from Sigma. Caspase-1 Activity Assay Kit purchased from Beoytime was used to perform the semi-quantitative analysis of mature caspase-1 activity.</p></sec><sec id="Sec16"><title>Mice</title><p id="Par35"><italic>Neat1</italic><sup>−/−</sup> mice on a C57BL/6 background were generated by Biocytogen Biological Technology Co., Ltd. Briefly, C57BL/6 mice and Kunming (KM) mice were housed in a specific pathogen free facility. For <italic>Neat1</italic> targeting, two sgRNAs (Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>) were designed to target either a region upstream or downstream of the gene <italic>Neat1</italic>. For each targeting site, candidate guide RNAs were designed by the CRISPR design tool (<ext-link xlink:href="http://crispr.mit.edu" ext-link-type="url">http://crispr.mit.edu</ext-link>). Guide RNAs were screened for on-target activity use UCATM. UCATM (Universal CRISPR Activity Assay), a sgRNA activity detection system developed by Biocytogen, is simpler and more sensitive than MSDase assay. The Cas9 mRNA and sgRNAs were transcribed by T7 RNA polymerase in vitro. For Cas9 mRNA and sgRNAs production, add the T7 promoter sequence to the Cas9 or sgRNA template by PCR amplification. The T7-Cas/sgRNA PCR products was gel purified and used as the template for in vitro transcription using the MEGA shortscript T7 kit (Life Technologies) according to the kit protocol. Purify the Cas9 mRNA and sgRNAs using the MEGAclear kit and elute with RNase-free water. C57BL/6 female mice and KM mouse strains were used as embryo donors and pseudopregnant foster mothers, respectively. Superovulated female C57BL/6 mice (3–4 weeks old) were mated to C57BL/6 stud males, and fertilized embryos were collected from the ampullae of super ovulated. Different concentrations of Cas9 mRNA and sgRNAs were mixed and co-injected into the cytoplasm of one-cell stage fertilized eggs. After injection, surviving zygotes were transferred into oviducts of KM albino pseudopregnant females. Sixty-five pups were born and then identified by genotyping with tail DNA. <italic>Neat1</italic><sup><italic>+/−</italic></sup> mice were used furtherly to reproduce the next generation, which includes <italic>Neat1</italic><sup>−/−</sup> mice and <italic>Neat1</italic><sup>+/+</sup> mice. <italic>IL-6</italic><sup>−/−</sup> mice were provided by professor Zexiong Lian’s laboratory. Genotyping PCR primers sequences are shown in Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>. All animal experiments were undertaken and conducted with approval from the Animal Research Ethics Committee of the University of Science and Technology of China (Permit Number: USTCACUC1801057).</p></sec><sec id="Sec17"><title>Cell culture</title><p id="Par36">IBMDM, L929, and 293T cell lines were cultured in DMEM (Dulbecco’s modified Eagle’s medium) medium containing 10% fetal bovine serum. iBMDM and L929 cell lines were kindly provided by professor Rongbin Zhou. 293T cell lines (ATCC CRL-3216) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All cells were tested for mycoplasma contamination by Cell Culture Contamination Detection Kit (ThermoFisher).</p></sec><sec id="Sec18"><title>Cell stimulation</title><p id="Par37">Macrophages were cultured in DMEM complemented with 10% FBS, 1 mM sodium pyruvate, and 2 mM L-glutamine overnight, and the medium was changed to opti-MEM in the following morning. Cells were primed with LPS (100 ng/mL) for 3 h, and subsequently stimulated with nigericin (5 μM) for 0.5 h to activate NLRP3 inflammasome, DOTAP-transfected flagellin (0.5 μg/mL) for 3 h to activate NLRC4 inflammasome, Lipofectamine 2000-transfected poly(dA:dT) (1 μg/mL) for 3 h to activate AIM2 inflammasome or 2DG (50 mM) for 4 h to activate Nlrp1b inflammasome. Total cell lysates, precipitated supernatants, and pellets of cells at different stages were analyzed by immunoblotting.</p></sec><sec id="Sec19"><title>CLIP sequencing</title><p id="Par38">CLIP was performed as previously described<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. Briefly, two 10-cm dishes of iBMDM cells were stimulated with LPS for 3 h followed by treated with nigericin for 0.5 h. Activated iBMDMs were washed three times with cold PBS, and irradiated at 150 mJ/cm<sup>2</sup> at 254 nm in HL-2000 HybriLinker<sup>TM</sup> UV Crosslinker. Cells were collected and resuspended in 1 ml lysis buffer (50 mM Tris–HCl [pH 7.4], 100 mM NaCl, 1% Igepal CA-630, 0.1% SDS, 0.5% sodium deoxycholate, 1/25 volume of Roche Protease Inhibitor Cocktail, 40 U/mL RNase inhibitor, 20 μM MG132) for 20 min Cell lysates were precleared with protein A/G beads (Pierce), and then were incubated with protein A/G beads coated with NLRP3 antibody at 4 °C for 3 h. After extensive washing with washing buffer (50 mM Tris–HCl [pH 7.4], 100 mM NaCl, 0.2% Igepal CA-630, 0.1% SDS, 0.5% sodium deoxycholate, 40 U/mL RNase inhibitor), the bead-bound immunocomplexes were eluted using elution buffer (50 mM Tris-HCl, pH 8.0, 1% SDS, and 10 mM EDTA) at 65 °C for 10 min. To isolate protein-associated RNAs from the eluted immunocomplexes, samples were treated with proteinase K, and RNAs were extracted by phenol/chloroform. The RNA sequencing was performed and analyzed by KangChen Bio-tech, Shanghai, China. The sequencing data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus database (GSE118722). Visualization analysis was performed by Integrative Genomics Viewer (IGV).</p></sec><sec id="Sec20"><title>Propidium iodide staining and imaging</title><p id="Par39">To examine pyroptotic cells, cells were treated as indicated in 12-well plates for image capture. Propidium iodide (1 μg/mL) was added to the medium for monitoring cell membrane integrity. Static bright-field images of pyroptotic cells were captured using an Olympus IX71.</p></sec><sec id="Sec21"><title>Immunoprecipitation and RNA pull-down</title><p id="Par40">For immunoprecipitation assay, the lysates of iBMDMs were incubated with 2 μg/ml antibody recognizing particular protein or normal rabbit/mouse IgG at 4 °C for 2 h, and then with 20 μl protein A/G magnetic beads for 1 h. After washing three times with lysis buffer (50 mM Tris–HCl [pH 7.4], 100 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 1/25 volume of Roche Protease Inhibitor Cocktail, 40 U/ml RNase inhibitor, and 20 μM MG132), the immunocomplexes were analyzed by western blotting or real-time RT-PCR. For RNA pull-down with biotin-labeled DNA probes, cell lysates were incubated with biotinylated sense or antisense DNA oligomers (1 μM, Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>) corresponding to <italic>Neat1</italic> for 2 h, and then with 20-μl streptavidin-coupled agarose beads for 1 h. After extensive washing, the precipitated complexes were analyzed by real-time RT-PCR and western blotting. For RNA pull-down with in vitro biotin-labeled <italic>Neat1_1</italic>, 3-μg in vitro-synthesized biotin-labeled <italic>Neat1_1</italic> was incubated with lysates from indicated iBMDM cells (4 × 10<sup>7</sup>) for 3 h. Streptavidin-coupled agarose beads (Invitrogen) were then added to the reaction mix to isolate the RNA–protein complex. For RNA immunoprecipitation (RIP), indicated cell lysates were precleared with 20-μl protein A/G beads, and then incubated with 20-μl protein A/G beads coated with indicated antibodies at 4 °C for 2 h. After extensive washing and elution, immunocomplexes were analyzed by real-time RT-PCR and western blotting. Primers used for template amplification are shown in Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>.</p></sec><sec id="Sec22"><title>RNA fluorescence in situ hybridization following by immunofluorescence</title><p id="Par41">In order to detect <italic>Neat1</italic> and ASC in a same cell, RNA FISH was firstly carried out as previously described<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> with in vitro transcribed antisense probes (Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>) labeled by Nucleic Acid Labeling Kits (Life technologies, USA) with Alexa Fluor 488. Then fluorescence probes-labeled cells were stained with rabbit anti-ASC and Alexa fluor 647 donkey anti-rabbit IgG as described in the next item.</p></sec><sec id="Sec23"><title>Immunofluorescence</title><p id="Par42">IBMDMs, seeded in glass-bottom dishes were treated with indicated conditions. The cells were fixed with 4% paraformaldehyde in PBS for 30 min, permeabilized with 0.5% Triton X-100 in PBS for 15 min, rinsed, blocked with 5% BSA in PBS for 30 min, and then incubated with indicated primary antibodies overnight at 4 °C. the next morning, cells were washed three times with PBST (0.05% Tween-20 in PBS) and were recognized with indicated fluorescence-labeled secondary antibodies. After extensive washing with PBST, cells were imaging.</p></sec><sec id="Sec24"><title>Pellets preparation and western blotting</title><p id="Par43">Cells were harvested after LPS and nigericin co-treatment, resuspended in 0.3 mL buffer (20 mM Hepes [pH 7.5], 150 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM EGTA, 1 mM EDTA, 320 mM sucrose, 1/25 volume of Roche Protease Inhibitor Cocktail, 40 U/mL RNase inhibitor, 20 μM MG132) lysed by shearing 10 times through a 27-gauge syringe. After centrifugation (520 × <italic>g</italic>, 8 min), supernatants were mixed with equal volumes of CHAPS buffer (20 mM Hepes-KOH [pH 7.5], 5 mM MgCl<sub>2</sub>, 0.5 mM EGTA, and 0.1% CHAPS) and centrifuged (4000 × g) for another 8 min to pellet the ASC pyroptosomes. The pellets then were resuspended in CHAPS buffer containing 2 mM disuccinimidyl suberate (DSS) and incubated for 30 min followed by centrifugation (4000 × g, 10 min). Pellets were fractionated on 12% SDS/PAGE and detected by immunoblotting with ASC antibody. Furthermore, western blotting was performed by the method described previously<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>.</p></sec><sec id="Sec25"><title>Enzyme-linked immunosorbent assay</title><p id="Par44">Supernatants from cell culture were assayed for mouse IL-1β and mouse TNF-α according to manufacturer’s instructions of ELISA kits (R&amp;D).</p></sec><sec id="Sec26"><title>Cytosolic and nuclear fractionation</title><p id="Par45">Indicated cells were incubated with hypotonic buffer (25 mM Tris-HCl, pH 7.4, 1 mM MgCl<sub>2</sub>, 5 mM KCl) on ice for 5 min. An equal volume of hypotonic buffer containing 1% NP-40 was then added, and each sample was left on ice for another 5 min. After centrifugation at 5000 × <italic>g</italic> for 5 min, the supernatant was collected as the cytosolic fraction. The pellets were resuspended in nucleus resuspension buffer (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF) and incubated at 4 °C for 30 min. Nuclear fraction was collected after removing insoluble membrane debris by centrifugation at 12,000 × <italic>g</italic> for 10 min.</p></sec><sec id="Sec27"><title>Real-time RT-PCR</title><p id="Par46">Total RNA was isolated by TRIzol reagent (Invitrogen). One microgram of RNA was used to synthesize cDNA using the RT Master Mix (Takara). Real-time PCR was performed using SYBR Green real-time PCR analysis (Takara) with the specific primers (Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). PCR results, recorded as cycle threshold (Ct), were normalized against an internal control (<italic>Actin</italic>).</p></sec><sec id="Sec28"><title>In vivo peritonitis</title><p id="Par47">Wild-type or <italic>Neat1</italic> knockout mice (males, 8 weeks old) were i.p. injected with 35 mg/kg Alum for 12 h. Peritoneal cavities were washed with 6 mL of PBS. The peritoneal fluids were harvested and concentrated for ELISA analysis with Amicon Ultra 10 K from Millipore. The concentrations of mouse IL-1β were measured using ELISA kits (R&amp;D) according to the manufacturer’s instruction. PECs were analyzed by flow cytometry<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>.</p></sec><sec id="Sec29"><title>In vivo pneumonia</title><p id="Par48"><italic>Neat1</italic><sup>+/+</sup> or <italic>Neat1</italic><sup>−/−</sup> mice (males, 8 weeks old) were intranasally instilled with a mixture of flagellin (1 μg per mouse) and TurboFect in vivo transfection reagent in a total volume of 50 μL for 12 h to induce pneumonia or with isotonic saline for 12 h as negative control. BALF was obtained by lavaging the lung with 3 mL PBS containing soybean trypsin inhibitor (100 μg/mL). The concentrations of mouse IL-1β were measured using ELISA kits (R&amp;D). BALCs in BALF were analyzed by flow cytometry.</p></sec><sec id="Sec30"><title>Flow cytometry</title><p id="Par49">PECs and BALCs were obtained and blocked in PBS with 20% rat serum for 0.5 h. After washing three times with PBS, cells were incubated with PerCP-CyTM5.5-mouse CD11b antibody, APC-mouse Ly-6G antibody, and PE-mouse Ly-6C antibody for 1 h. After washing three times with PBS, stained cells were analyzed on the BD FACSCalibur to detect the proportion of neutrophils or Ly-6C<sup>+</sup> monocytes. The flow cytometry data were analyzed on FlowJo software with the gating strategies indicated in Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">10</xref>.</p></sec><sec id="Sec31"><title>shRNAs and siRNAs</title><p id="Par50">Forward (F) and reverse (R) DNA fragments (Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>) were annealed and then cloned into plasmid pLKO.1, which was used for gene knockdown in iBMDMs. siRNAs were used for gene knockdown in BMDMs. siRNAs’ target sequences are shown in Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>.</p></sec><sec id="Sec32"><title>Reporting Summary</title><p id="Par51">Further information on experimental design is available in the <xref ref-type="supplementary-material" rid="MOESM3">Nature Research Reporting Summary</xref> linked to this article.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thank Professor Zexiong Lian (South China University of Technology) for kindly providing <italic>IL-6</italic><sup>−/−</sup> mice. This work was supported by grants from the National Key R&amp;D Program of China (2018YFA0107103 and 2016YFC1302302) and the National Natural Science Foundation of China (81430065 and 81820108021) to M.W. and the U.S. National Institutes of Health (R01CA182675 and R01CA184867) to X.Y.</p></ack><sec sec-type="author-contribution"><title>Author contributions</title><p>P.Z., L.C., X.Y. and M.W. designed research; P.Z. and L.C. performed experiments and analyzed data; R.Z. helped to initiate this project and provided material support; P.Z., X.Y. and M.W. wrote and revised the manuscript.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>All relevant data are available from the corresponding authors upon reasonable request. The source data underlying all reported averages in Figs. <xref ref-type="supplementary-material" rid="MOESM4">1</xref>b, c, e, g, i, <xref ref-type="supplementary-material" rid="MOESM4">4</xref>a–d, <xref ref-type="supplementary-material" rid="MOESM4">5</xref>b, d, e, f, <xref ref-type="supplementary-material" rid="MOESM4">6</xref>b, d, f, <xref ref-type="supplementary-material" rid="MOESM4">7</xref>a–c, <xref ref-type="supplementary-material" rid="MOESM4">8</xref>g, h, <xref ref-type="supplementary-material" rid="MOESM4">10</xref>a–h and Supplementary Figs. <xref ref-type="supplementary-material" rid="MOESM4">1</xref>c–i, k, l, <xref ref-type="supplementary-material" rid="MOESM4">3</xref>b–e, <xref ref-type="supplementary-material" rid="MOESM4">4</xref>a–h, <xref ref-type="supplementary-material" rid="MOESM4">7</xref>a–g, <xref ref-type="supplementary-material" rid="MOESM4">8f</xref>, <xref ref-type="supplementary-material" rid="MOESM4">9a</xref> are provided in Source Data File. The source data underlying all uncropped versions of the blots and gels presented in Figs. <xref ref-type="supplementary-material" rid="MOESM4">1</xref>a, d, f, h, <xref ref-type="supplementary-material" rid="MOESM4">2</xref>a–h, <xref ref-type="supplementary-material" rid="MOESM4">3</xref>a–d, <xref ref-type="supplementary-material" rid="MOESM4">4</xref>a–f, <xref ref-type="supplementary-material" rid="MOESM4">5</xref>a, c, <xref ref-type="supplementary-material" rid="MOESM4">8</xref>a–c, e, f, <xref ref-type="supplementary-material" rid="MOESM4">9a–i</xref> and Supplementary Figs. <xref ref-type="supplementary-material" rid="MOESM4">1</xref>j, m, <xref ref-type="supplementary-material" rid="MOESM4">2</xref>a, b, <xref ref-type="supplementary-material" rid="MOESM4">3a</xref>, <xref ref-type="supplementary-material" rid="MOESM4">4</xref>f, h, <xref ref-type="supplementary-material" rid="MOESM4">5</xref>d, <xref ref-type="supplementary-material" rid="MOESM4">6</xref>a–e, <xref ref-type="supplementary-material" rid="MOESM4">8</xref>a, d, e, <xref ref-type="supplementary-material" rid="MOESM4">9b</xref> are also provided in Source Data File. The sequencing data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus database (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118722" ext-link-type="url">GSE118722</ext-link>).</p></sec><sec sec-type="ethics-statement"><sec id="FPar1" sec-type="COI-statement"><title>Competing interests</title><p id="Par52">The authors declare no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf</article-title><source>Nature</source><year>2004</year><volume>430</volume><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="bibcode">2004Natur.430..213M</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXlsVGjsrk%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature02664</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The inflammasomes</article-title><source>Cell</source><year>2010</year><volume>140</volume><fpage>821</fpage><lpage>832</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXlsVSgu78%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.040</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strowig</surname><given-names>T</given-names></name><name><surname>Henao-Mejia</surname><given-names>J</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name><name><surname>Flavell</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Inflammasomes in health and disease</article-title><source>Nature</source><year>2012</year><volume>481</volume><fpage>278</fpage><lpage>286</lpage><pub-id pub-id-type="bibcode">2012Natur.481..278S</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xps1GmsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature10759</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>SL</given-names></name><name><surname>Cookson</surname><given-names>BT</given-names></name></person-group><article-title xml:lang="en">Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells</article-title><source>Infect. Immun.</source><year>2005</year><volume>73</volume><fpage>1907</fpage><lpage>1916</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXjtFygt78%3D</pub-id><pub-id pub-id-type="doi">10.1128/IAI.73.4.1907-1916.2005</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Coyne</surname><given-names>CB</given-names></name><name><surname>Zeh</surname><given-names>HJ</given-names></name><name><surname>Lotze</surname><given-names>MT</given-names></name></person-group><article-title xml:lang="en">PAMPs and DAMPs: signal 0s that spur autophagy and immunity</article-title><source>Immunol. Rev.</source><year>2012</year><volume>249</volume><fpage>158</fpage><lpage>175</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhsFCnu7jN</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-065X.2012.01146.x</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinon</surname><given-names>F</given-names></name><name><surname>Mayor</surname><given-names>A</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The Inflammasomes: guardians of the Body</article-title><source>Annu. Rev. Immunol.</source><year>2009</year><volume>27</volume><fpage>229</fpage><lpage>265</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXlsFSlsbc%3D</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132715</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><article-title xml:lang="en">Inflammasomes: mechanism of assembly, regulation and signalling</article-title><source>Nat. Rev. Immunol.</source><year>2016</year><volume>16</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xps1Srt7k%3D</pub-id><pub-id pub-id-type="doi">10.1038/nri.2016.58</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>MR</given-names></name><name><surname>Kaminski</surname><given-names>JJ</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name></person-group><article-title xml:lang="en">Pattern recognition receptors and the innate immune response to viral infection</article-title><source>Virus.-Basel</source><year>2011</year><volume>3</volume><fpage>920</fpage><lpage>940</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXotF2msr8%3D</pub-id><pub-id pub-id-type="doi">10.3390/v3060920</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>TD</given-names></name><etal/></person-group><article-title xml:lang="en">Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3</article-title><source>Nature</source><year>2006</year><volume>440</volume><fpage>233</fpage><lpage>236</lpage><pub-id pub-id-type="bibcode">2006Natur.440..233K</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XitFGitLk%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature04517</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Cryopyrin activates the inflammasome in response to toxins and ATP</article-title><source>Nature</source><year>2006</year><volume>440</volume><fpage>228</fpage><lpage>232</lpage><pub-id pub-id-type="bibcode">2006Natur.440..228M</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XitFGitLs%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature04515</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinon</surname><given-names>F</given-names></name><name><surname>Agostini</surname><given-names>L</given-names></name><name><surname>Meylan</surname><given-names>E</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome</article-title><source>Curr. Biol.</source><year>2004</year><volume>14</volume><fpage>1929</fpage><lpage>1934</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXpsVOrtr8%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2004.10.027</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Schroder</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?</article-title><source>Nat. Rev. Immunol.</source><year>2010</year><volume>10</volume><fpage>210</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXitFelsro%3D</pub-id><pub-id pub-id-type="doi">10.1038/nri2725</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>HB</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><article-title xml:lang="en">The caspase-1 inflammasome: a pilot of innate immune responses</article-title><source>Cell Host. Microbe</source><year>2008</year><volume>4</volume><fpage>198</fpage><lpage>208</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtF2jt7vE</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2008.08.007</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages</article-title><source>J. Immunol.</source><year>1997</year><volume>159</volume><fpage>1451</fpage><lpage>1458</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2sXkslKrtLo%3D</pub-id><pub-id pub-id-type="pmid">9233643</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Planillo</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">K + Efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter</article-title><source>Immunity</source><year>2013</year><volume>38</volume><fpage>1142</fpage><lpage>1153</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtVaitb3M</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2013.05.016</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perregaux</surname><given-names>D</given-names></name><name><surname>Gabel</surname><given-names>CA</given-names></name></person-group><article-title xml:lang="en">Interleukin-1-beta maturation and release in response to ATP and nigericin—evidence that potassium-depletion mediated by these agents is a necessary and common feature of their activity</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>15195</fpage><lpage>15203</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2cXksFGlsLg%3D</pub-id><pub-id pub-id-type="pmid">8195155</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marim</surname><given-names>FM</given-names></name><etal/></person-group><article-title xml:lang="en">The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection</article-title><source>Semin. Immunopathol.</source><year>2017</year><volume>39</volume><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXit1Wht7s%3D</pub-id><pub-id pub-id-type="doi">10.1007/s00281-016-0581-1</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>D</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title xml:lang="en">The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation</article-title><source>J. Cell Biol.</source><year>2016</year><volume>213</volume><fpage>617</fpage><lpage>629</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvVWktrvP</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201602089</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title xml:lang="en">Anti-inflammatory agents: present and future</article-title><source>Cell</source><year>2010</year><volume>140</volume><fpage>935</fpage><lpage>950</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXlsVSgu7c%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.043</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>V</given-names></name><etal/></person-group><article-title xml:lang="en">AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>514</fpage><lpage>U516</lpage><pub-id pub-id-type="bibcode">2009Natur.458..514H</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXht1ehu7w%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature07725</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>596</fpage><lpage>U257</lpage><pub-id pub-id-type="bibcode">2011Natur.477..596Z</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtFKqsb7P</pub-id><pub-id pub-id-type="doi">10.1038/nature10510</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyden</surname><given-names>ED</given-names></name><name><surname>Dietrich</surname><given-names>WF</given-names></name></person-group><article-title xml:lang="en">Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin</article-title><source>Nat. Genet.</source><year>2006</year><volume>38</volume><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XotlGksA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/ng1724</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>KC</given-names></name><name><surname>Mogridge</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Activation of the Nlrp1b inflammasome by reduction of cytosolic ATP</article-title><source>Infect. Immun.</source><year>2013</year><volume>81</volume><fpage>570</fpage><lpage>579</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXlt1SntLw%3D</pub-id><pub-id pub-id-type="doi">10.1128/IAI.01003-12</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>4763</fpage><lpage>4768</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXmt1egtr0%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1620458114</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannahill</surname><given-names>GM</given-names></name><etal/></person-group><article-title xml:lang="en">Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>238-+</fpage><pub-id pub-id-type="bibcode">2013Natur.496..238T</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXkvFyjsrk%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature11986</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derrien</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1775</fpage><lpage>1789</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtlentLvO</pub-id><pub-id pub-id-type="doi">10.1101/gr.132159.111</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorio</surname><given-names>MV</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name></person-group><article-title xml:lang="en">MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. a comprehensive review</article-title><source>EMBO Mol. Med.</source><year>2012</year><volume>4</volume><fpage>143</fpage><lpage>159</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XjsVSqs70%3D</pub-id><pub-id pub-id-type="doi">10.1002/emmm.201100209</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Dinger</surname><given-names>ME</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name></person-group><article-title xml:lang="en">Long non-coding RNAs: insights into functions</article-title><source>Nat. Rev. Genet.</source><year>2009</year><volume>10</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhvFGlu7k%3D</pub-id><pub-id pub-id-type="doi">10.1038/nrg2521</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasanth</surname><given-names>KV</given-names></name><name><surname>Spector</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">Eukaryotic regulatory RNAs: an answer to the ‘genome complexity’ conundrum</article-title><source>Gene Dev.</source><year>2007</year><volume>21</volume><fpage>11</fpage><lpage>42</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmsFylsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1101/gad.1484207</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrow</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">GENCODE: the reference human genome annotation for The ENCODE Project</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1760</fpage><lpage>1774</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtlentLvN</pub-id><pub-id pub-id-type="doi">10.1101/gr.135350.111</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabili</surname><given-names>MN</given-names></name><etal/></person-group><article-title xml:lang="en">Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses</article-title><source>Gene Dev.</source><year>2011</year><volume>25</volume><fpage>1915</fpage><lpage>1927</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXht1Oju7zI</pub-id><pub-id pub-id-type="doi">10.1101/gad.17446611</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Yi, H. et al. LincRNA-Gm4419 knockdown ameliorates NF-kappa B/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. <italic>Cell Death Dis</italic>. <bold>8</bold>, e2583 (2017).</mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>GK</given-names></name><etal/></person-group><article-title xml:lang="en">LincRNA-Cox2 promotes late inflammatory gene transcription in macrophages through modulating SWI/SNF-mediated chromatin remodeling</article-title><source>J. Immunol.</source><year>2016</year><volume>196</volume><fpage>2799</fpage><lpage>2808</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XjvVygsrg%3D</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1502146</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atianand</surname><given-names>MK</given-names></name><etal/></person-group><article-title xml:lang="en">A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>1672</fpage><lpage>1685</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtVWlurvL</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.075</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>YTF</given-names></name><name><surname>Ideue</surname><given-names>T</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Mituyama</surname><given-names>T</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">MEN epsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>2525</fpage><lpage>2530</lpage><pub-id pub-id-type="bibcode">2009PNAS..106.2525S</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXislahsrg%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0807899106</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunwoo</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles</article-title><source>Genome Res.</source><year>2009</year><volume>19</volume><fpage>347</fpage><lpage>359</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXjt12ktbs%3D</pub-id><pub-id pub-id-type="doi">10.1101/gr.087775.108</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>FF</given-names></name><etal/></person-group><article-title xml:lang="en">Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus</article-title><source>J. Autoimmun.</source><year>2016</year><volume>75</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xht12jtLvI</pub-id><pub-id pub-id-type="doi">10.1016/j.jaut.2016.07.012</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinon</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Signaling by ROS drives inflammasome activation</article-title><source>Eur. J. Immunol.</source><year>2010</year><volume>40</volume><fpage>616</fpage><lpage>619</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXjtVWktbc%3D</pub-id><pub-id pub-id-type="doi">10.1002/eji.200940168</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>AB</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name></person-group><article-title xml:lang="en">Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection</article-title><source>Aging</source><year>2011</year><volume>3</volume><fpage>304</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXkvFKjt7c%3D</pub-id><pub-id pub-id-type="doi">10.18632/aging.100292</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Clair</surname><given-names>DKS</given-names></name></person-group><article-title xml:lang="en">ROS and p53: a versatile partnership</article-title><source>Free Radic. Biol. Med.</source><year>2008</year><volume>44</volume><fpage>1529</fpage><lpage>1535</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXktlGls7o%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.01.011</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Ruegg</surname><given-names>A</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Beer</surname><given-names>HD</given-names></name></person-group><article-title xml:lang="en">Active caspase-1 is a regulator of unconventional protein secretion</article-title><source>Cell</source><year>2008</year><volume>132</volume><fpage>818</fpage><lpage>831</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXjs1ait74%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2007.12.040</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Opdenbosch</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><pub-id pub-id-type="doi">10.1038/ncomms4209</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>D</given-names></name><name><surname>McClendon</surname><given-names>CL</given-names></name><name><surname>Jacobson</surname><given-names>MP</given-names></name><name><surname>Wells</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>9971</fpage><lpage>9981</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXlsVCqurk%3D</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.426460</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Boucher, D. et al. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. <italic>J. Exp. Med.</italic><bold>215</bold>, 827–840 <ext-link xlink:href="https://doi.org/10.1084/jem.20172222" ext-link-type="doi">https://doi.org/10.1084/jem.20172222</ext-link> (2018).</mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergsbaken</surname><given-names>T</given-names></name><name><surname>Fink</surname><given-names>SL</given-names></name><name><surname>Cookson</surname><given-names>BT</given-names></name></person-group><article-title xml:lang="en">Pyroptosis: host cell death and inflammation</article-title><source>Nat. Rev. Microbiol.</source><year>2009</year><volume>7</volume><fpage>99</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXlvFynug%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro2070</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Hutchinson, J. N. et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. <italic>BMC Genomics</italic><bold>8</bold>, 39 (2007).</mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Cellular localization of NLRP3 inflammasome</article-title><source>Protein Cell</source><year>2013</year><volume>4</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXpsVyksLs%3D</pub-id><pub-id pub-id-type="doi">10.1007/s13238-013-2113-2</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Bakele, M. et al. Localization and functionality of the inflammasome in neutrophils. <italic>J. Biol. Chem</italic>. <bold>289</bold>, 5320–5329 <ext-link xlink:href="https://doi.org/10.1074/jbc.M113.505636" ext-link-type="doi">https://doi.org/10.1074/jbc.M113.505636</ext-link> (2014).</mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landeras-Bueno</surname><given-names>S</given-names></name><name><surname>Ortín</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Regulation of influenza virus infection by long non-coding RNAs</article-title><source>Virus Res.</source><year>2016</year><volume>212</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsVKktL7M</pub-id><pub-id pub-id-type="doi">10.1016/j.virusres.2015.08.008</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title xml:lang="en">NEAT1 modulates herpes simplex virus-1 replication by regulating viral gene transcription</article-title><source>Cell. Mol. Life Sci.</source><year>2017</year><volume>74</volume><fpage>1117</fpage><lpage>1131</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhslegsL3P</pub-id><pub-id pub-id-type="doi">10.1007/s00018-016-2398-4</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adriaens</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity</article-title><source>Nat. Med.</source><year>2016</year><volume>22</volume><fpage>861</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtV2msb7M</pub-id><pub-id pub-id-type="doi">10.1038/nm.4135</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegh</surname><given-names>AH</given-names></name></person-group><article-title xml:lang="en">Targeting the p53 signaling pathway in cancer therapy—the promises, challenges and perils</article-title><source>Expert Opin. Ther. Tar.</source><year>2012</year><volume>16</volume><fpage>67</fpage><lpage>83</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xos1Wltw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1517/14728222.2011.643299</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>CA</given-names></name><etal/></person-group><article-title xml:lang="en">Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression</article-title><source>Cell</source><year>2011</year><volume>145</volume><fpage>571</fpage><lpage>583</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXmtFGmtLk%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2011.03.035</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhry</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Tumor hypoxia induces nuclear paraspeckle formation through HIF-2 alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival</article-title><source>Oncogene</source><year>2015</year><volume>34</volume><fpage>4482</fpage><lpage>4490</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhvFKmur%2FK</pub-id><pub-id pub-id-type="doi">10.1038/onc.2014.378</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhry</surname><given-names>H</given-names></name><name><surname>Mole</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Hypoxic regulation of the noncoding genome and NEAT1</article-title><source>Brief. Funct. Genom.</source><year>2016</year><volume>15</volume><fpage>174</fpage><lpage>185</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXlsVSrsL8%3D</pub-id><pub-id pub-id-type="doi">10.1093/bfgp/elv050</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXisVKisb0%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatica</surname><given-names>A</given-names></name><name><surname>Bozzoni</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Long non-coding RNAs: new players in cell differentiation and development</article-title><source>Nat. Rev. Genet.</source><year>2014</year><volume>15</volume><fpage>7</fpage><lpage>21</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvVKgtrzO</pub-id><pub-id pub-id-type="doi">10.1038/nrg3606</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heward</surname><given-names>JA</given-names></name><name><surname>Lindsay</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Long non-coding RNAs in the regulation of the immune response</article-title><source>Trends Immunol.</source><year>2014</year><volume>35</volume><fpage>408</fpage><lpage>419</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtleisb%2FI</pub-id><pub-id pub-id-type="doi">10.1016/j.it.2014.07.005</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>CL</given-names></name><etal/></person-group><article-title xml:lang="en">A long noncoding RNA connects c-Myc to tumor metabolism</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>18697</fpage><lpage>18702</lpage><pub-id pub-id-type="bibcode">2014PNAS..11118697H</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitFCrt7zN</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1415669112</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name></person-group><article-title xml:lang="en">Structure and function of long noncoding RNAs in epigenetic regulation</article-title><source>Nat. Struct. Mol. Biol.</source><year>2013</year><volume>20</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXjsFOhu74%3D</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.2480</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>HT</given-names></name><name><surname>Callaway</surname><given-names>JB</given-names></name><name><surname>Ting</surname><given-names>JPY</given-names></name></person-group><article-title xml:lang="en">Inflammasomes: mechanism of action, role in disease, and therapeutics</article-title><source>Nat. Med.</source><year>2015</year><volume>21</volume><fpage>677</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nm.3893</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>JA</given-names></name><name><surname>Canna</surname><given-names>SW</given-names></name></person-group><article-title xml:lang="en">The NLRC4 Inflammasome</article-title><source>Immunol. Rev.</source><year>2018</year><volume>281</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhvFOqsrnJ</pub-id><pub-id pub-id-type="doi">10.1111/imr.12607</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugrin</surname><given-names>J</given-names></name><name><surname>Martinon</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">The AIM2 inflammasome: Sensor of pathogens and cellular perturbations</article-title><source>Immunol. Rev.</source><year>2018</year><volume>281</volume><fpage>99</fpage><lpage>114</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhvFOqsrbM</pub-id><pub-id pub-id-type="doi">10.1111/imr.12618</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes-Alnemri</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>JW</given-names></name><name><surname>Datta</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>JH</given-names></name><name><surname>Alnemri</surname><given-names>ES</given-names></name></person-group><article-title xml:lang="en">AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>509</fpage><lpage>U505</lpage><pub-id pub-id-type="bibcode">2009Natur.458..509F</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXht1eht78%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature07710</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DA</given-names></name><name><surname>Giaccia</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">Hypoxia, gene expression, and metastasis</article-title><source>Cancer Metast Rev.</source><year>2007</year><volume>26</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXotFWrtbw%3D</pub-id><pub-id pub-id-type="doi">10.1007/s10555-007-9063-1</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groslambert</surname><given-names>M</given-names></name><name><surname>Py</surname><given-names>BF</given-names></name></person-group><article-title xml:lang="en">Spotlight on the NLRP3 inflammasome pathway</article-title><source>J. Inflamm. Res.</source><year>2018</year><volume>11</volume><fpage>359</fpage><pub-id pub-id-type="doi">10.2147/JIR.S141220</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppertz</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">iCLIP: Protein-RNA interactions at nucleotide resolution</article-title><source>Methods</source><year>2014</year><volume>65</volume><fpage>274</fpage><lpage>287</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvVWnsL7L</pub-id><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.10.011</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ule</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">CLIP identifies Nova-regulated RNA networks in the brain</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>1212</fpage><lpage>1215</lpage><pub-id pub-id-type="bibcode">2003Sci...302.1212U</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXpt1Smtr0%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1090095</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="other">Cao, L. M., Zhang, P. F., Li, J. M. &amp; Wu, M. LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells. <italic>Elife</italic><bold>6</bold>, e30433 (2017).</mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>WJ</given-names></name><etal/></person-group><article-title xml:lang="en">TAp73 enhances the pentose phosphate pathway and supports cell proliferation</article-title><source>Nat. Cell Biol.</source><year>2013</year><volume>15</volume><fpage>991</fpage><lpage>U242</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtVaiurbL</pub-id><pub-id pub-id-type="doi">10.1038/ncb2789</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec33"><title>Supplementary information</title><p id="Par53"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_9482_MOESM1_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Supplementary Information</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_9482_MOESM2_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Peer Review File</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_9482_MOESM3_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Reporting Summary</p></caption></media></supplementary-material></p></sec><sec id="Sec34"><title>Source Data</title><p id="Par54"><supplementary-material content-type="local-data" id="MOESM4" xlink:title="Source Data"><media xlink:href="MediaObjects/41467_2019_9482_MOESM4_ESM.xlsx" mimetype="application" mime-subtype="vnd.ms-excel"><caption xml:lang="en"><p>Source Data</p></caption></media></supplementary-material></p></sec></app></app-group><notes notes-type="ESMHint"><title>Supplementary information</title><p><bold>Supplementary Information</bold> accompanies this paper at <ext-link xlink:href="https://doi.org/10.1038/s41467-019-09482-6" ext-link-type="doi">https://doi.org/10.1038/s41467-019-09482-6</ext-link>.</p></notes><notes notes-type="Misc"><p><bold>Journal peer review information:</bold><italic>Nature Communications</italic> thanks Tsan Xiao and the other anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p></notes><notes notes-type="Misc"><p><bold>Publisher’s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Science, Humanities and Social Sciences, multidisciplinary</facet-value><facet-value count="1">Science, multidisciplinary</facet-value></facet><facet name="keyword"/><facet name="pub"><facet-value count="1">Nature Communications</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value><facet-value count="1">United States</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
